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Epithelial-mesenchymal transition of tubular epithelial cells in Epithelial-mesenchymal transformation (EMT) and,
human renal biopsies. more in general, transdifferentiation are concepts origi-
Background. In recent studies performed on cultured cells nally belonging to developmental biology and oncologyand experimental nephropathies, it has been hypothesized that
[1]. Cell shifting between epithelial and mesenchymaltubular epithelial cells (TEC), via epithelial-mesenchymal trans-
formation (EMT), can become collagen-producing cells. Ac- phenotype, by turning on and off specific genes during
cording to this theory, they should proceed through several early development, is a well recognized process that char-
activating steps, such as proliferation and phenotype changes, acterizes the embryonal plasticity [2]. EMT also can beto eventually synthesize extracellular matrix (ECM).
a key element in development of metastasis of tumorsMethods. To evaluate whether EMT operates in human
TECs, 133 renal biopsies of different renal diseases were stud- derived from epithelial tissues; in fact, mesenchymal cells
ied, analyzing by immunohistochemistry and in situ hybridiza- have the ability to invade and migrate through the extra-
tion the possible expression of markers of proliferation (PCNA, cellular matrix, a property not present in the epithelialMib-1), cellular phenotype (vimentin, -SMA, cytokeratin,
lineage [3, 4]. More recent evidence for transdifferentia-ZO-1) and ECM production (prolyl 4-hydroxylase, HSP47,
tion has been observed in almost all mature tissues,interstitial collagens).
Results. Independently of histological diagnosis, variable de- where the process seems to be mainly related to wound
grees of TEC positivity for PCNA (2.7  2.4 cells/field) and healing and fibrotic remodeling after inflammatory in-Mib-1 (1.9  2.3) were present. TECs expressing vimentin
jury [5–8]. For instance, in the liver, it has been demon-(1.4  4.7) and -smooth muscle actin (-SMA; 0.04  0.4)
strated that, after adequate stimulation, Ito cells losealso were detected. It was possible to observe loss of epithelial
antigens from 8 to 10% of the tubular cross sections. Moreover, their original function of storing vitamin A and become
TECs were stained by prolyl 4-hydroxylase (3.6  4.3), heat collagen-producing cells [9].
shock protein-47 (HSP47; 2.9  5.4), collagen type I (0.2 
In the kidney, for several years interstitial fibrosis has2.7) and type III (0.3  2.0). Collagen types I and III mRNAs
been considered a common mechanism of disease pro-were found in 0.8 to 1.4 cells/field. The number of TEC with
EMT features were associated with serum creatinine and the gression [10, 11] that, at a certain point, becomes inde-
degree of interstitial damage (P  0.03), and even considering pendent of the initial cause of disease and is linked tothe 45 cases with mild interstitial lesions, the tubular expression
a pathological imbalance between extracellular matrixof all markers remained strictly associated with renal function
deposition and degradation, which is stimulated by a(P  0.01).
Conclusions. Our results suggest that, via transition to a variety of cytokines and growth factors [12].
mesenchymal phenotype, TEC can produce ECM proteins in Fibroblasts are the pivotal effector cells in fibrogen-
human disease and directly intervene in the fibrotic processes.
esis. Originally identified through light and electron mi-Moreover, the association of EMT features with serum creati-
croscopy on the basis of their morphology and only morenine supports the value of these markers in the assessment of
disease severity. recently by fibroblast markers, they display a great heter-
ogeneity that is not only organ-dependent but also due
to the anatomic location and the microenvironment inKey words: transdifferentiation, collagen-producing cells, extracellular
matrix, fibrosis, cell development, inflammatory injury. the same organ [13]. In the kidney, Bohman identified two
distinct populations in the cortex and in the inner medullaReceived for publication January 23, 2001
[14] that display further morphological and functional dif-and in revised form January 18, 2002
Accepted for publication March 4, 2002 ferences according to the stage of differentiation or pres-
ence of disease [15–17]. 2002 by the International Society of Nephrology
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Table 1. Histological diagnosis of renal biopsies junction protein ZO-1 (Zymed) and cytokeratin interme-
included in the study
diate filaments (MNF116; Dako) were applied as epithe-
Histological diagnosis Number of cases lial markers. Among various broad-spectrum antibodies
Minimal change disease 9 against cytokeratins, MNF116 was selected because in
Membranous nephropathy 20 normal human kidneys it stained all tubular cross sec-
IgA glomerulonephritis 55
tions. Possible tubular cell production of collagen wasPrimary FSGS 19
Membranoproliferative GN 5 tested with antibodies directed against alpha-chain and
Systemic lupus erythematosus 4 beta-chain of the enzyme prolyl 4-hydroxylase (Accu-
Diabetic glomerulosclerosis 13
rate, Chemical & Scientific Corporation, Westbury, NY,ANCA-positive renal vasculitis 3
Nephroangiosclerosis 5 USA), and HSP47 (colligin; StressGen Biotechnologies
Corp, DBA Italia SRL, Milan, Italy). Moreover, since it
is known by collagen IV synthesis that tubular cells in-
tervene in tubular basement membrane formation [22],
we tested possible interstitial collagen production throughGiven the complexity of the cell lineage, the origin of
renal fibroblasts remains controversial. At present the antibodies against interstitial collagens type I (Sigma)
and type III (Monosan; Biospa, Milan, Italy). Interstitialprevailing theory favors resident interstitial cells [18],
but other authors have previously postulated a fibroblast leukocyte infiltration was identified by an antibody against
leukocyte common antigen (CD45; Immunotech).derivation from migrating leukocytes. Recent studies on
cultured cells and experimental nephropathies [19–21] An avidin-biotin technique was used as previously de-
scribed, in which a biotinylated secondary antibody re-have hypothesized that epithelial-mesenchymal transfor-
mation can occur in tubular epithelial cells, which should acts with several peroxidase-conjugated streptavidin
molecules [23].then be able to migrate to the interstitium and produce
extracellular matrix proteins. Briefly, after incubation with 0.5% avidin (Sigma) and
0.01% biotin (Sigma), to suppress endogenous avidin-To evaluate this hypothesis in humans, we used immu-
nohistochemistry and in situ hybridization to study the binding activity, tissue sections were fixed in a methanol-
H2O2 solution (to block endogenous peroxidase). Afterexpression of several markers of possible tubular pheno-
type transition and extracellular matrix production in washing, sections were sequentially incubated with the
primary antibody, with the secondary biotinylated anti-133 kidney biopsies and 10 normal kidneys.
body (Zymed) and with the peroxidase-labeled streptavi-
din (Zymed). Peroxidase activity was detected with
METHODS
3,5-diaminobenzidine (DAB) (Sigma), and then sections
Kidney tissue were counterstained with Harry’s hematoxylin (DDK,
Milan, Italy), dehydrated and mounted in PermountKidney tissue was obtained from 133 renal biopsies of
different types of renal disease and, for comparison, from (DDK). Periodic acid Schiff (PAS) counterstaining was
alternatively performed to evaluate the integrity of tubu-10 cadaver kidneys that could not be grafted because of
vascular abnormalities (Table 1). lar basement membrane.
Specificity of antibody labeling was demonstrated byTissue samples for light microscopy and in situ hybrid-
ization staining were fixed in 4% buffered paraformalde- the lack of staining after substituting phosphate buffer
saline (PBS) and proper control immunoglobulins (Zy-hyde and embedded in paraffin. Routine stainings were
performed according to standard techniques. med) for the primary antibody.
For immunofluorescence and immunoperoxidase stain-
Double staininging the unfixed renal tissue was embedded in OCT com-
pound (Miles Scientific, Naperville, IL, USA), snap-frozen A double staining method was applied to examine the
relationship between epithelial and mesenchymal anti-in a mixture of isopentane and dry-ice and stored at
80C. Subsequently, 5 m sections were placed on slides gens, using the antibody against cytokeratins coupled
with mesenchymal or ECM production markers. Ac-and stored at 20C until immunostaining.
cording to the double staining procedure published by
Immunoperoxidase labeling Lan et al [24], sections were treated as for the single
stain from the beginning of the procedure to the DABTubular cells entering the cell cycle were assessed by
antibodies directed against proliferating cell nuclear anti- development, except for the use of TBS instead of PBS.
After washing, sections were then microwaved twicegen (PCNA; Dako Italia, Milan, Italy) and Mib-1 (Ki-67;
Immunotech, Marseille, France). As mesenchymal mark- at 750 W for five minutes in citrate buffer. They were se-
quentially cooled, pre-treated with levamisole, pre-incu-ers, monoclonal antibodies against vimentin (HistoLine;
Zymed, Milan, Italy) and alpha-smooth muscle actin bated with normal serum, and incubated with the second
primary antibody. After washing in TBS, sections were(-SMA; Zymed) were used. Antibodies against the tight
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then labeled with a biotinylated secondary antibody ded, were sequentially treated for in situ hybridization
and immunohistochemistry as described earlier in this(Zymed) and alkaline phosphatase-conjugated-strepta-
vidin (Zymed). Alkaline phosphatase activity was finally article for the single stain procedures. To develop the
reactions obtaining different colors, sections were pre-detected with Fast Red (Sigma). After washing in dis-
tilled water and counterstaining with Mayer’s hematoxy- treated with levamisole, and amplification of in situ hy-
bridization procedure was made by an alkaline phospha-lin (Sigma), sections were then mounted with an aqueous
mounting medium (Kaiser’s Glycerin Jelly; DDK). Spec- tase (AP)-conjugated monoclonal anti-FITC antibody
(Dako). Alkaline phosphatase activity was detected withificity of labeling was demonstrated by the lack of stain-
ing after substituting TBS and irrelevant immunoglobu- Fast Red (Sigma). At the end of immunohistochemistry,
immunoperoxidase activity was detected with DAB, andlins for the first and/or second primary antibody.
then sections were not dehydrated, but mounted with
In situ hybridization an aqueous mounting medium (Kaiser’s Glycerin Jelly;
DDK).To identify the cells responsible for interstitial colla-
gen production, in situ hybridization was performed us-
Quantitative evaluationing probes specific for human collagen type I and type III.
Following the method published by Yamawaki et al, All peroxidase-stained sections and trichrome-stained
sections were evaluated by an electronic image analysistissues were deparaffinized and rehydrated, then perme-
abilized with saponin-EBSS [25]. Postfixation was car- system (ETC3000, Graftek; Villanterio, Pavia, Italy). Im-
ages were digitalized using a videocamera (Kappa CF15/2,ried out with 4% buffered paraformaldehyde. Sections
were then acetylated with a solution of acetic-anidride/ Gleichen, Germany) connected to a Leitz Diaplan micro-
scope (Leica, Milan, Italy) and to a Pentium 120 com-trietanolamine. After washing, a prehybridization solu-
tion, containing standard sodium citrate (SSC)  10, puter (Maxwel, Rozzano, Italy) equipped with a frame
grabber (Neotech Ltd, Eastleigh Hampshire, UK).Denhardt’s solution 10, formamide 50%, Dextran sul-
fate 10% and salmon sperm DNA 200 g/mL (all from Cell count required a color threshold procedure, fol-
Sigma), was applied for one hour. Oligonucleotide digox- lowed by filtering and Danielsson algorithm. Tubular pos-
igenin-labeled probes specific for collagen type I and itivity for proliferative, mesenchymal and ECM markers
type III (Roche Molecular Biochemicals, Milan, Italy) were counted as number of positive cells per field (200).
were appropriately diluted in the prehybridization so- Tubular loss of cytokeratins and ZO-1 were instead as-
lution and applied overnight in a water-saturated atmo- sessed as percentage of tubular cross sections. Interstitial
sphere. After hybridization, stringency washes were done infiltration was finally evaluated in consecutive high
with SSC  4, SSC  2–50% formamide at 45C, and power fields (400), and results calculated as the number
again with SSC 1 at room temperature for 30 minutes. of positive cells per square millimeter.
After incubation in peroxidase quenching solution (3% Interstitial fibrosis evaluation, assessed on trichrome
H2O2), specimens were incubated with anti-digoxigenin stained sections, was made by an optical threshold on
antibody fluorescein isothiocyanate (FITC)-labeled (Zy- the extracted hue plane followed by filtering, and was
med) for one hour. Further amplification was obtained calculated as percentage of the total scanned area.
incubating sections with a horseradish peroxidase (HRP)- All results were automatically exported and elabo-
conjugated monoclonal anti-FITC antibody, according rated using SPSS 9.0 program and expressed as mean
to manufacturer instructions (Zymed). The enzymatic and standard deviation of the mean (SPSS Inc., Chicago,
reaction was finally developed with DAB (Sigma). After IL, USA). Statistical significances (P  0.05) were ana-
washing in distilled water, sections were dehydrated and lyzed using the 	2 test.
mounted with Permount (DDK). Positive controls were
done using digoxigenin-labeled oligos for housekeeping
RESULTSgenes (
-actin and G6PDH) and oligo-dT (R&D Sys-
The results are summarized in Table 2.tems, Abingdon, UK).
In normal kidneys rare tubular epithelial cells wereNegative controls were made using irrelevant oligonu-
labeled by PCNA (0.06  0.8/field) (min 0  max 1.6),cleotides (that is, digoxigenin-labeled oligonucleotide for
whereas none of them were found positive for Mib-1.rat insulin; R&D Systems) or sense oligonucleotides
All mesenchymal and ECM production markers were(Roche) and substituting the prehybridization solution
completely negative on tubular cells, which expressedfor the probe solution.
cytokeratins and ZO-1 on 100% tubular cross sections.
Immunohistochemistry coupled to in situ hybridization In situ hybridization for interstitial collagens did not
reveal any tubular positivity.The technique was performed to simultaneously detect
Renal biopsies, independently of histological diagno-interstitial collagen protein and mRNA. Briefly, 5-m
thick renal sections, formalin-fixed and paraffin-embed- sis, showed variable degrees of tubular positivity for all
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Table 2. Immunohistochemistry and in situ hybridization results
P values
Normal Renal Interstitial Interstitial
Markers studied kidneys biopsies Screat Uprot infiltrates fibrosis
PCNA 0.060.8 2.72.4 0.002 NS 0.003 0.001
Mib-1 0 1.92.3 0.006 NS 0.002 0.002
Vimentin 0 1.44.7 0.03 0.003 0.003 0.003
-SMA 0 0.040.4 0.02 NS 0.0003 0.0003
Cytokeratin lossa 0 8.512.0 0.003 NS 0.002 0.003
ZO-1 lossa 0 1022.2 0.006 NS 0.003 0.005
P 4-H alpha chain 0 3.64.3 0.005 NS 0.0001 0.0001
P 4-H beta chain 0 5.64.2 0.009 NS 0.0001 0.0001
HSP47 0 2.95.4 0.004 NS 0.0001 0.0001
Collagen type I 0 0.22.7 0.01 0.05 0.001 0.001
Collagen type I mRNA 0 1.43.3 0.008 0.04 0.0007 0.0006
Collagen type III 0 0.32.0 0.02 NS 0.005 0.006
Collagen type III mRNA 0 0.92.7 0.009 NS 0.003 0.003
Results are evaluated as number of positive tubular epithelial cells/field (200). Association with clinicohistological parameters are given (P values).
a Loss of epithelial antigens are calculated as percentage of tubular cross sections
markers. PCNA stained 2.7 2.4 tubular epithelial cells/ protein was clearly accumulated in the interstitium, but
field (TEC/f) (min 0  max 4.8) and Mib-1 was positive also in areas characterized by protein expression limited
on 1.9  2.3 (min 0  max 3.9; Fig. 1). Tubular vimentin to the tubular basement membrane (Fig. 7).
positivity was detected on 1.4 4.7 TEC/f (min 0max Independently of disease diagnosis, all markers were
6.7), whereas -SMA was observed on very few cells, significantly associated with some clinico-histological pa-
being present on 0.04  0.4 TEC/f (min 0  max 0.9; rameters at time of renal biopsy: serum creatinine (P 
Fig. 2). A loss of cytokeratins was found on 8.5  12.0% 0.03), interstitial infiltration (P  0.003) and interstitial
tubular cross sections (min 0  max 35%) and ZO-1 fibrosis (P  0.003). The association with urinary pro-
staining was absent from 10.0  22.2% (min 0  max teins was mostly not significant.
48%; Fig. 3). Labeling for prolyl 4-hydroxylase alpha Among the diagnostic groups, we did not observe
chain was observed on 3.6  4.3 TEC/f (min 0  max relevant quantitative differences in the expression of all
8.6), whereas the beta chain of the enzyme was positive markers. Minimal change disease only was characterized
on 5.6  4.2 of them (min 0  max 19.6). HSP47 was by the highest percentage of cases resembling normal
detected on 2.9 5.4 TEC/f (min 0max 9). A variable kidneys (8 of 9 cases, corresponding to 89%), without
number of tubular cells also were labeled by the antibod- any sign of possible EMT in tubular cells. IgA nephri-
ies raised against collagen type I (0.2  2.7; min 0  tis accounted for a number of cases (N  55) sufficient
max 4.3), and collagen type III (0.3  2.0; min 0  max to perform a statistical analysis that confirmed the as-
3.6; Fig. 4). sociation of immunohistochemical and in situ hybridi-
Especially evident in cases with none or mild intersti- zation results with serum creatinine and tubulointer-
tial fibrosis, positivity for mesenchymal and ECM anti- stitial damage.
gens and loss of epithelial properties were mainly de- To evaluate the potential usefulness of these markers
tected in well preserved tubular structures, without signs in the assessment of tubular cell alterations, independently
of tubular basement membrane (TBM) disruption and of well established tubulointerstitial lesions, we selected
possible cell migration into the interstitium, as demon- among all cases 45 biopsies on the basis of their mild
strated by PAS counterstain (Fig. 5). interstitial infiltration (less than 250 CD45  cells/mm2)
By double staining, in addition to normal tubules, only and fibrosis (less than 15%). In this group of biopsies the
cytokeratin-positive, tubules containing both cytokera- expression of EMT markers was significantly associated
tins and mesenchymal or ECM markers were observed with serum creatinine (P  0.01).
(Fig. 6). Tubular cells stained only by mesenchymal or
ECM markers were rarely found.
DISCUSSIONBy in situ hybridization 1.4  3.3 tubular cells/field
Taken together, our results suggest that in human kid-(min 0  max 5.6) were positive for collagen type I
ney diseases tubular epithelial cells, via their transitionmRNA, and 0.9  2.7 (min 0  max 4.2) for collagen
to a mesenchymal phenotype, by themselves can producetype III mRNA. Immunohistochemistry coupled with in
extracellular matrix proteins and directly intervene insitu hybridization for collagen type I and type III showed
tubular mRNA expression not only in areas where the fibrotic processes.
Fig. 1. Normal kidney and membranoproli-
ferative glomerulonephritis. In a normal kid-
ney proliferating cell nuclear antigen (PCNA)
stains few interstitial cells (a, IPX, 100). At
higher magnification (b), it is evident that the
few PCNA positive cells are tubular epithelial
cells (IPX, 400). Membranoproliferative glo-
merulonephritis in a kidney showing several
tubules positive for proliferative markers,
both PCNA (c) and Mib-1 (d) (IPX, 100).
Fig. 3. Normal kidney and lupus nephritis. In
a normal kidney, the anti-cytokeratin anti-
body MNF116 (a; IPX, 100) and the tight
junction protein ZO-1 (e; IPX,400) are pres-
ent in all tubular cross sections. In the kidney
with lupus nephritis, some tubuli do not stain
for cytokeratins (b; IPX,200), and at higher
magnification the loss appears disomogeneous
(c and d; IPX, 1000), while some tubular
cross sections are negative for ZO-1 ( f ; IPX,
200).
Fig. 2. Normal kidney and primary focal and
segmental glomerulosclerosis. The mesenchy-
mal markers vimentin (a) and -smooth mus-
cle actin (-SMA) (c) are completely negative
in tubular cells of a normal kidney (IPX,
100). Primary focal and segmental glomeru-
losclerosis (b, d) where several vimentin-
stained tubular epithelial cells are present (b;
IPX, 200) and a tubular cross section con-
tains -SMA positive cells (d; IPX, 400).
Fig. 4. Normal and membranous nephropathy
kidneys. In a normal kidney, the proteins involved
in collagen synthesis, prolyl 4-hydroxilase- chain
(P4H-; a) and heat shock protein 47 (HSP47; c)
are completely negative, while collagen type I does
not stain tubular epithelial cells and is scarcely
expressed in the interstitium (e; IPX, 100). In
the kidney with membranous nephropathy, several
tubules appear P4H- and HSP47 positive (b and
d; IPX,200), while tubular cell positivity for col-
lagen type I is associated to an increased positivity
among tubules (f; IPX, 400).
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Fig. 6. Diabetic glomerulosclerosis. A tubule that is only cytokeratin
positive (in red) is surrounded by several tubules double-stained by
cytokeratins (in red) and P4H- chain (in brown; IPX-AP, 400).
ative events [12, 21]. Very recently it has been hypothe-
sized that tubular epithelial cells can transdifferentiate
to a mesenchymal phenotype, migrate to the interstitium
and behave as proper fibroblasts [19–21, 30].
Generally speaking, the process of epithelial-mesen-
chymal transformation implies various activating steps,
including proliferation, phenotype changes, and ability
to produce extracellular matrix proteins [9].
Increased proliferation of tubular cells has been docu-
mented especially in culture after activating stimuli [31–33],
but has been demonstrated in vivo as well [34, 35]. Inter-
estingly, Nadasdy et al observed that a high tubular pro-
liferation rate characterizes atrophic-appearing tubules
that show a higher proliferation index than normal and
Fig. 5. Lupus nephritis. P4H- positivity involves two tubular cross damaged but non-atrophic tubular cells [35]. Our results
sections (a; IPX, PAS counterstain, 200). It is evident, especially at provide evidence for an increased tubular cell prolifera-
higher magnification (b) that the tubular basement membrane sur-
tion in human biopsies taken from patients with differentrounding the positive tubule is thickened, but not disrupted (IPX,400,
PAS counterstain). renal diseases, in which both of the antigens studied
(PCNA and Mib-1) were found to be positive in a greater
amount of tubules compared to normal kidneys. These
aspects suggest an attempt to repair the damage, as it
For several years it has been well known that tubular occurs after ischemic injury [36].
epithelial cells, far from being innocent bystanders of re- Phenotypic modulation is common among renal cells
nal damage, actively participate to the interstitial events and not surprising because of the common derivation
that occur during both immunologically- and non-immu- (apart from collecting duct cells) from the metanephro-
nologically–mediated renal disease [26–28]. First evi- genic mesenchyme. Glomerular endothelial as well as
dence for their direct implication was obtained with the mesangial and epithelial cells, both in cultures and in
discovery that they can act as antigen presenting cells animal experimental models, have been shown to un-
through the expression of HLA class II antigens and dergo phenotypic changes as consequence of damage
adhesion molecules (reviewed by Rubin-Kelley and Jev- [37–39]. In the absence of specific fibroblast markers,
nikar) [29]. Moreover, in the last years, a growing body except for FSP1 [19], which unfortunately is not specific
of evidence has documented their ability to produce a for human fibroblasts, most authors have focused on the
variety of chemokines, cytokines and growth factors that appearance of mesenchymal markers in tubular epithe-
lial cells.further contribute to interstitial inflammatory and repar-
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studied in renal pathology, whose interstitial expres-
sion currently is considered one of the best predictors
of disease progression [44–47]. -SMA characterizes the
so-called myofibroblast, a cell morphologically interme-
diate between fibroblast and smooth muscle cell [48],
and has been detected in tubular cells of 5/6-nephrecto-
mized rats by Ng et al [49]. The authors describe tubular
labeling by -SMA increasing with time after nephrec-
tomy and in strict correlation with tubular basement
membrane disruption and signs of possible tubular cell
migration toward the interstitium. However, the latest
article from the same group showed that -SMA posi-
tivity also was in intact tubules in humans [50]; our results
are in complete agreement with their study.
Besides the presence of mesenchymal markers, a good
criterion to evaluate possible signs of epithelial-mesen-
chymal transition is the disappearance of intermediate
filaments of keratin type, which has been already docu-
mented in cultured mouse tubular cells [20] and recently
in human biopsies [50]. Moreover, a decrease in cell-cell
adhesion with the reduction of junctional proteins has
been described by Healy et al [30, 51]. Our results con-
firm that both these events characterize tubular cells
during renal damage.
In our biopsies, the presence of tubules showing only
mesenchymal markers was a rare finding. The great ma-
jority of tubules with mesenchymal antigen positivity
were also cytokeratin positive by double staining, con-
firming in our opinion the existence of different steps of
phenotype transition. Previous data obtained in culture
cells and experimental nephritis clearly demonstrated
this concept. In fact, a transient and completely revers-
ible phenotypic modulation was observed after exposure
to a mild and transient initial insult, whereas a permanent
transition was present in rat kidneys with severe pro-Fig. 7. Nephroangiosclerosis and IgA nephropathy. (a) In situ hybrid-
ization negative control with nephroangiosclerosis performed using a gressing glomerulonephritis [38].
sense oligonucleotide for collagen type I demonstrates a complete nega- To our knowledge never studied in renal cells, prolyl
tivity (digoxigenin-anti-digoxigenin-IPX, 100). (b) IgA nephropathy
4-hydroxylase is a crucial enzyme for synthesis of colla-shows collagen type I in situ hybridization (in red) followed by collagen
type I immunohistochemistry (in brown). An interstitial area shows a gen and of proteins with collagen-like sequences [52]. It
strong expression of both the mRNA (in red) and the protein (in catalyzes in fact the formation of 4-hydroxyproline, and
brown). Some mRNA positive tubules (in red) are present also in areas
not only enables the cell to collagen production, butcharacterized by less interstitial protein accumulation, where the protein
appears to stain only the tubular basement membrane (digoxigenin- also controls its correct release from the endoplasmic
anti-digoxigenin-AP/IPX, 100). reticulum [53]. The active protein is a tetramer composed
by two alpha and two beta chains, with an exceeding
synthesis of beta chain that also possesses an indepen-
dent disulfide isomerase activity [53, 54]. The presenceVimentin filaments are the hallmark of cells derived
of the alpha chain is essential for tetramer assembly andfrom mesenchymal tissues. Constitutively present in cul-
activity, containing both the binding and the catalytictured tubular epithelial cells [40], they have been found
sites. In our experience normal kidneys did not show tu-in vivo only in diseased kidneys of both animals [41, 42]
bular cell labeling for the alpha nor the beta chain. In-and humans [43]. In agreement with Essawy et al, who
stead, positivity for both the enzyme chains was evidentdemonstrated tubular positivity for vimentin in human
in some tubules of most renal biopsies, and showed abiopsies of kidneys with fibrotic lesions [44], we found
larger number of cells stained by the beta chain, in agree-this marker to be positive in many of our tissues.
ment with the enzyme synthesis pathway. These resultsA very rare finding, at least in our experience, was
the positivity of tubular cells for-SMA, a marker widely were supported also by a corresponding tubular positi-
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vity for HSP47, recognized as a collagen specific molecu- relation between tubular positivity for mesenchymal an-
tigens and the excretion of proteins of a very low molecu-lar chaperone that plays a pivotal role in the biosynthesis,
processing, and secretion of procollagen from endoplas- lar weight, which might indicate a less preserved tubular
reabsorption due to damage of the tubular epithelialmic reticulum [55].
Consistent with these findings, tubular epithelial cells cells (manuscript in preparation).
In conclusion, our study confirms previous data andwere positive for interstitial collagens, both protein and
mRNA. Interestingly, by in situ hybridization coupled indicates that phenotype variations in humans character-
ize tubular epithelial cells during disease, independentlywith immunohistochemistry, we detected mRNA posi-
tive tubules not only in areas of interstitial collagen of the etiology. Many questions remain, especially about
the timing of these changes and their possible reversibil-accumulation, but also in areas where the correspond-
ing protein was only expressed by the tubular basement ity [8, 38, 62]. Since they seem to eventually enable tubu-
lar cells to produce extracellular matrix proteins directly,membrane.
In summary, although the theory of transdifferentia- they give tubular cells further centrality in the progres-
sion of renal damage.tion implies that after phenotypic changes tubular cells
migrate into the interstitium where they become proper
fibroblasts, we found immunohistochemical and in situ hy- ACKNOWLEDGMENTS
bridization features of transdifferentiation also in cells This work done on behalf of EU Concerted Action “Chronic In-
flammation leading to scarring, the major mechanism for kidney fail-belonging to still well-recognizable tubular structures, in
ure” (http://www. kidney-euract.org). Some results were presented aswhich no apparent signs of possible migration toward the
an invited lecture at the ECM-2000 meeting held in Go¨ttingen, Ger-
interstitium were present. These aspects were especially many, June 1-3, 2000.
evident and prevalent in cases with no or only mild signs
Reprint requests to Maria Pia Rastaldi, M.D., Renal Research Associ-of tubulointerstitial damage, and obviously we do not ex-
ation, c/o Renal Immunopathology Center, San Carlo Borromeo Hospi-
clude a possible subsequent interstitial migration of trans- tal, Via Pio II, 3, 20153 Milan, Italy.
E-mail: mp.rastaldi@oscb.sined.netdifferentiated tubular cells. Nevertheless, from our data
we consider another hypothesis: after injury, some tubular
cells undergo proliferation and dedifferentiation in the at- REFERENCES
tempt to repair the damage, and this gives them the ability 1. Hay ED: An overview of epithelio-mesenchymal transformation.
Acta Anat 154:8–20, 1995to produce not only collagen type IV, but also interstitial
2. Boyer B, Thiery JP: Epithelium-mesenchyme interconversion ascollagens, as has been observed not only in vitro [56–58],
example of epithelial plasticity. APMIS 101:257–268, 1993
but also in vivo [50, 59]. It is already well known that 3. Jouanneau J, Tucker GC, Boyer B, et al: Epithelial cell plasticity
in neoplasia. Cancer Cells 3:525–529, 1991basement membrane composition has a profound in-
4. Mareel MM, Van Roy FM, De Baetselier P: The invasive pheno-fluence on epithelial cell behavior [60] and alterations
types. Cancer Metastasis Rev 9:45–62, 1990
of the TBM can induce tubular cell transdifferentiation 5. Clark RAF: Wound repair. Curr Op Cell Biol 1:1000–1008, 1989
6. Vidal S, Horvath E, Kovacs K, et al: Transdifferentiation of[22]. For these reasons we believe that interstitial colla-
somatotrophs to thyrotrophs in the pituitary of patients with pro-gen deposition into the TBM, by altering its composition,
tracted primary hypothyroidism. Virchows Arch 436:43–51, 2000
can create a vicious circle that perpetuates and enhances 7. d’Amati G, di Gioia CR, Giordano C, Gallo P: Myocyte transdif-
ferentiation: A possible pathogenetic mechanism for arrhythmo-the damage.
genic right ventricular cardiomyopathy. Arch Pathol Lab Med 124:In our study, tubular phenotype alterations were strictly
287–290, 2000
associated with the degree of renal functional impair- 8. Paranya G, Vineberg S, Dvorin E, et al: Aortic valve endothelial
cells undergo transforming growth factor-
-mediated and non-ment, with the number of interstitial leukocytes and with
transforming growth factor-
-mediated transdifferentiation inthe extent of interstitial fibrosis independently of histo-
vitro. Am J Pathol 159:1335–1343, 2001
logical diagnosis, confirming the hypothesis that from a 9. Gressner AM: Transdifferentiation of hepatic stellate cells (Ito
cells) to myofibroblasts: A key event in hepatic fibrogenesis. Kidneycertain point tubulointerstitial events become indepen-
Int 49(Suppl 54):S39–S45, 1996dent of the cause of renal disease and lead to progression
10. Bohle A, Grund KE, Mackensen S, Tolon M: Correlation be-
of damage [12, 27, 28, 30]. However, we found signs of tween renal interstitium and level of serum creatinine. Virchows
Arch A Pathol Anat Histol 373:15–23, 1977EMT in cases with mild interstitial inflammatory and
11. Bohle A, Strutz F, Mu¨ller GA: On the pathogenesis of chronicfibrotic damage. In these biopsies all antigens of tubular
renal failure in primary glomerulopathies: A view from the intersti-
proliferation, phenotype change and ECM production tium. Exp Nephrol 2:205–210, 1994
12. Becker JG, Hewitson TD: The role of tubulointerstitial injuryremained associated with serum creatinine levels, in our
in chronic renal failure. Curr Opin Nephrol Hypertens 9:133–opinion suggesting the value of these markers in early
138, 2000
or at least more precise detection of disease severity. 13. Sappino AP, Schu¨rch W, Gabbiani G: Differentiation repertoire
of fibroblastic cells: Expression of cytoskeletal proteins as markerThe absence of association with urinary proteins indi-
of phenotypic modulations. Lab Invest 63:144–161, 1990rectly supports the concept that quality and not quantity
14. Bohman SO: The ultrastructure of the renal interstitium, in Con-
of proteins is important for progression of the disease temporary issues in Nephrology, edited by Brenner BM, Stein
JH, New York, Churchill Livingstone, 1983, pp 1–34[61] and our laboratory’s results demonstrate a good cor-
Rastaldi et al: Tubular cell transdifferentiation146
15. Mu¨ller GA, Strutz FM: Renal fibroblast heterogeneity. Kidney to progressive glomerular damage? Kidney Int 45(Suppl 45):S58–
Int 48(Suppl 50):S33–S36, 1995 S63, 1994
16. Mu¨ller GA, Rodemann HP: Characterization of human renal 40. Strutz F, Renziehausen A, Dietrich M, et al: Cortical fibroblast
fibroblasts in health and disease. I. Immunophenotyping of cul- culture from human biopsies. J Nephrol 14:190–197, 2001
tured tubular epithelial cells and fibroblasts derived from kidneys 41. Nakatsuji S, Yamate J, Sakuma S: Relationship between vimentin
with histologically proven interstitial fibrosis. Am J Kidney Dis 17: expressing renal tubules and interstitial fibrosis in chronic progres-
680–683, 1991 sive nephropathy in aged rats. Virchows Arch 433:359–367, 1998
17. Rodemann HP, Mu¨ller GA: Characterization of human renal 42. Suzuki T, Kimura M, Asano M, et al: Role of atrophic tubules
fibroblasts in health and disease. II. In vitro growth, differentiation, in development of interstitial fibrosis in microembolism-induced
and collagen synthesis of fibroblasts from kidneys with interstitial renal failure in rat. Am J Pathol 158:75–85, 2001
fibrosis. Am J Kidney Dis 17:684–686, 1991 43. Ivanyi B, Hamilton-Dutoit SJ, Hansen HE, Olsen S: Acute
18. Ross R, Everett NB, Tyler R: Wound healing and collagen forma- tubulointerstitial nephritis: Phenotype of infiltrating cells and prog-
tion. VI. The origin of the wound: Fibroblasts studied in parabiosis. nostic impact of tubulitis. Virchows Arch 428:5–12, 1996
J Cell Biol 44:645–654, 1970 44. Essawy M, Soylemezoglu O, Muchaneta-Kubara EC, et al: Myo-
19. Strutz F, Okada H, Lo CW, et al: Identification and characteriza- fibroblasts and the progression of diabetic nephropathy. Nephrol
tion of a fibroblast marker: FSP1. J Cell Biol 130:393–405, 1995 Dial Transplant 12:43–50, 1997
20. Strutz F, Muller GA, Neilson EG: Transdifferentiation: A new 45. Zhang G, Moorhead PJ, el Nahas AM: Myofibroblasts and the
angle on renal fibrosis. Exp Nephrol 4:267–270, 1996 progression of experimental glomerulonephritis. Exp Nephrol 3:
21. Zeisberg M, Strutz F, Muller GA: Renal fibrosis: An update. 308–318, 1995
Curr Opin Nephrol Hypertens 10:315–320, 2001 46. Hewitson T, Becker G: Myofibroblast involvement in renal inter-
22. Zeisberg M, Bonner G, Maeshima Y, et al: Collagen composition stitial fibrosis. Nephrol 2:229–234, 1996
and assembly regulates epithelial-mesenchymal transdifferentia- 47. Roberts IS, Burrows C, Shanks JH, et al: Interstitial myofi-
tion. Am J Pathol 159:1313–1321, 2001 broblasts: Predictors of progression in membranous nephropathy.
23. Rastaldi MP, Ferrario F, Yang L, et al: Adhesion molecules J Clin Pathol 50:123–127, 1997
expression in non-crescentic acute post-streptococcal glomerulone- 48. Gabbiani G: The biology of the myofibroblast. Kidney Int 41:530–
phritis. J Am Soc Nephrol 7:2419–2427, 1996 532, 1992
24. Lan HY, Mu W, Nikolic-Paterson DJ, et al: A novel, simple, 49. Ng YY, Huang TP, Yang WC, et al: Tubular epithelial-myofi-
reliable, and sensitive method for multiple immunoenzyme stain- broblast transdifferentiation in progressive tubulointerstitial fi-
ing: Use of microwave oven heating to block antibody crossreactiv- brosis in 5/6 nephrectomized rats. Kidney Int 54:864–876, 1998
ity and retrieve antigens. J Histochem Cytochem 43:97–102, 1995 50. Jinde K, Nikolic-Paterson DJ, Huang XR, et al: Tubular pheno-
25. Yamawaki M, Zurbriggen A, Richard A, Vandevelde M: Sapo- typic change in progressive tubulointerstitial fibrosis in human
nin treatment for in situ hybridization maintains good morphologi- glomerulonephritis. Am J Kidney Dis 38:761–769, 2001
cal preservation. J Histochem Cytochem 41:105–109, 1993 51. Healy E, Leonard M, Madrigal-Estebas L, et al: Factors pro-
26. Cameron JS: Tubular and interstitial factors in the progression of duced by activated leukocytes alter renal epithelial cell differentia-
glomerulonephritis. Pediatr Nephrol 6:292–303, 1992 tion. Kidney Int 56:1266–1269, 1999
27. D’Amico G, Ferrario F, Rastaldi MP: Tubulointerstitial damage 52. Kivirikko KI, Myllyla¨ R, Pihlajaniemi T: Protein hydroxylation:
in glomerular diseases: Its role in the progression of renal damage. prolyl 4-hydroxylase, an enzyme with four cosubstrates and a multi-
Am J Kidney Dis 26:124–132, 1995 functional subunit. FASEB J 3:1609–1617, 1989
28. Klahr S: Mechanisms of progression of chronic renal damage. 53. Walmsley AR, Batten MR, Lad U, Bulleid NJ: Intracellular
J Nephrol 12(Suppl 2):S53–S62, 1999 retention of procollagen within the endoplasmic reticulum is medi-
29. Rubin-Kelley VE, Jevnikar AM: Antigen presentation by renal ated by prolyl 4-hydroxylase. J Biol Chem 274:14884–14892, 1999
tubular epithelial cells. J Am Soc Nephrol 2:13–26, 1991 54. Prockop DJ, Kivirikko KI: Collagens: molecular biology, diseases,
30. Healy E, Brady HR: Role of tubule epithelial cells in the patho- and potentials for therapy. Annu Rev Biochem 64:403–434, 1995
genesis of tubulointerstitial fibrosis induced by glomerular disease. 55. Nagata K: HSP 47: A collagen-specific molecular chaperone.
Curr Opin Nephrol Hypertens 7:525–530, 1998 Trends Biochem Sci 21:23–26, 199631. Mene` P: Molecular cell biology of renal diseases. J Nephrol 12:140– 56. Haverty TP, Kelly CJ, Hines WH, et al: Characterization of a149, 1999 renal tubular epithelial cell line which secretes the autologous32. Jones SC, Saunders HJ, Pollock CA: High glucose increases
target antigen of autoimmune experimental interstitial nephritis.growth and collagen synthesis in cultured human tubulointerstitial
J Cell Biol 107:1359–1367, 1988cells. Diabet Med 16:932–938, 1999
57. Ziyadeh F, Snipes ER, Watanabe M, et al: High glucose induces33. Dixon RJ, Young K, Brunskill NJ: Lysophosphatidic acid-
cell hypertrophy and stimulates collagen gene transcription in prox-induced calcium mobilization and proliferation in kidney proximal
imal tubule. Am J Physiol 259:F704–F714, 1990tubular cells. Am J Physiol 276:F191–F198, 1999
58. Creely JJ, Di Mari SJ, Howe AM, Haralson MA: Effects of34. Kerby JD, Luo KL, Ding Q, et al: Immunolocalization of acidic
transforming factor-
 on collagen synthesis by normal rat kidneyfibroblast growth factor and receptors in the tubulointerstitial com-
epithelial cells. Am J Pathol 140:45–55, 1992partment of chronically rejected human renal allografts. Trans-
59. Tang WW, Van GY, Qi M: Myofibroblast and 1(III) collagenplantation 63:988–995, 1997
expression in experimental tubulointerstitial nephritis. Kidney Int35. Nadasdy T, Laszik Z, Blick KE, et al: Tubular atrophy in the
51:926–931, 1997end-stage kidney: a lectin and immunohistochemical study. Hum
60. Lelievre SA, Weaver VM, Nickerson JA, et al: Tissue phenotypePathol 25:22–28, 1994
depends on reciprocal interactions between the extracellular ma-36. Witzgall R, Brown D, Schwarz C, Bonventre JV: Localization
trix and the structural organization of the nucleus. Proc Natl Acadof proliferating cell nuclear antigen, vimentin, c-Fos and clusterin
Sci USA 95:14711–14716, 1998in the postischemic kidney. Evidence for a heterogeneous genetic
61. Bazzi C, Petrini C, Rizza V, et al: Characterization of proteinuriaresponse among nephron segments, and a large pool of mitotically
in primary glomerulonephritides. SDS-PAGE patterns: Clinicalactive and dedifferentiated cells. J Clin Invest 93:2175–2188, 1994
significance and prognostic value of low molecular weight (“tubu-37. Savage COS: The biology of the glomerulus: endothelial cells.
lar”) proteins. Am J Kidney Dis 29:27–35, 1997Kidney Int 45:314–319, 1994
62. Danto SI, Shannon JM, Borok Z, et al: Reversible transdifferenti-38. Johnson RJ: The glomerular response to injury: progression or
ation of alveolar epithelial cells. Am J Respir Cell Mol Biol 12:497–resolution? Kidney Int 45:1769–1782, 1994
39. Rennke HG: How does glomerular epithelial cell injury contribute 502, 1995
